Fluorescence-guided Resection in Breast Cancer

计划入组 8 人 · 首次发布于 2010 年 4 月 27 日

MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT

计划入组 10 人 · 首次发布于 2015 年 8 月 19 日

Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours

计划入组 211 人 · 首次发布于 2018 年 10 月 5 日

L&J-PD

PD-(L)-1(ILAb)

Oral PD-L1,DICE Therapeutics

PD-RX Pharmaceuticals, Inc.

United States

CLEVELAND CLINIC ABUDHABI L L C

United Arab Emirates

ARNOLD, L EUGENE

United States

Instil Bio and ImmuneOnco Advance PD-(L)1xVEGF Bispecific Antibody Clinical Development Strategy

Jefferies Upgrades Instil Bio, Highlighting Potential of SYN2510 in Cancer Treatment

Sino Biopharmaceutical Acquires LaNova Medicines for $951 Million, Targeting PD-1xVEGF Cancer Therapies